LabGenius presents a scientific poster at drug discovery conference, Discovery UK

26 October 2021

Senior Scientist, Jordan Lane, presents a scientific poster that demonstrates how we've applied our platform to optimize multiple protein properties simultaneously.

---

---

About LabGenius

Headquartered in London, LabGenius is a leading machine learning-driven protein engineering company. The company’s core technology platform, EVA™, enables the rapid discovery of novel therapeutic antibodies. LabGenius’ highly multidisciplinary team brings together the very best minds from the fields of computer science, robotic automation and synthetic biology.

For more information, please visit www.labgeni.us, or connect on Twitter and LinkedIn.

For more information, please contact:

Media enquiries:
Communications Lead
Lucy Shaw
press@labgeni.us

Business development:
Chief Operating Officer
Didier Landais
didier.landais@labgeni.us

---